After paying $305m, Anne Wojcicki is back at the helm of 23andMe – the genetic data company she cofounded, ran, then left ...

After the company filed for bankruptcy in March, this week, the sale of 23andMe was completed after previously being approved by a judge.

An obesity drug from Hengrui Pharma and Kailera Therapeutics succeeded in a late-stage trial in China, while Anne Wojcicki’s ...

23andMe customers use saliva-based DNA testing kits to learn about their ancestry and potential gene-based risks for disease. The company stores the data — and spit samples — and sends users an ...

TTAM Research Institute acquires 23andMe in a $305 million bankruptcy sale, transitioning the DNA testing giant to a ...

A bankruptcy judge approved the sale of 23andMe's assets and business operations to a nonprofit led by 23andMe’s co-founder and former chief executive, Anne Wojcicki.

That means Wojcicki’s nonprofit TTAM Research Institute will purchase “substantially all” of San Francisco-based 23andMe’s assets for $305 million. The transaction — which arrives more than three ...

A bankruptcy court this week approved the $305 million sale of genetics testing firm 23andMe to a nonprofit organization led ...

This editorial originally ran in fellow CNHI paper The (Sunbury). Individuals have long valued privacy for themselves and their families, while often — knowingly or unknowingly — giving it away. It is ...

"It has always been a sale of DNA to a third party." TTAM Research won a bankruptcy auction for 23andMe’s assets in June, ...

When it comes to groundbreaking biotech advancements, Eric Faw Intellia is a name you might wanna keep an eye on. This ...

New research from the Perelman School of Medicine at the University of Pennsylvania has challenged the belief that the likelihood of finding undiagnosed genetic conditions decreases with age. “Our ...